| Product Name | MF | CAS | Details |
|---|
| Cycloshizukaol A | C32H36O8 | 150033-85-5 | Details |
| 2-Amino-3,5-dichloropyridine | C5H4Cl2N2 | 4214-74-8 | Details |
| 4-{5H,6H,7H-Pyrrolo[2,1-c][1,2,4]triazol-3-ylmethyl}aniline | C12H14N4 | 1094285-37-6 | Details |
| 3-(Dimethylamino)-3-phenylpropanoic acid hydrochloride | C11H16ClNO2 | 85608-26-0 | Details |
| 1-(Azepan-1-yl)-2-hydroxyethan-1-one | C8H15NO2 | 51068-58-7 | Details |
| 2-Chloro-N-(3-cyano-4,5-dimethylfuran-2-yl)propanamide | C10H11ClN2O2 | 1306603-87-1 | Details |
| 1-Acetyl-1,2,3,4-tetrahydro-quinoline-6-sulfonyl chloride | C11H12ClNO3S | 868964-04-9 | Details |
| NSP-805 | C17H19N3O2 | 125068-54-4 | Details |
| NFKP p100/p52 antibody (Ser865) | Details |
| 6-Bromo-2,2,4-trimethyl-1,2-dihydroquinoline | C12H14BrN | 91720-32-0 | Details |
| 7-aminopyrazolo[1,5-a]pyrimidine-3,6-dicarbonitrile | C8H4N6 | 119270-27-8 | Details |
| Ranibizumab - 10mM histidine- histidine HCl buffer | C11H12N2O2 | 347396-82-1 | Details |
| 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-isoquinolin-1-one | C15H18BNO3 | 1219130-56-9 | Details |
| {Spiro[3.3]heptan-2-yl}methanol | C8H14O | 4483-67-4 | Details |
| 2-(2,2-dimethylpropanoyl)-3-(3-(trifluoromethyl)phenyl)prop-2-enenitrile | C15H14F3NO | 391649-97-1 | Details |
| (E)-Pent-3-en-1-ol | C5H10O | 764-37-4 | Details |
| H-Ile-Ser-OH trifluoroacetic acid | C9H18N2O4 | 6403-14-1 | Details |
| PDHB antibody | Details |
| 2-[Benzyl(methyl)ao]propanoic acid | C11H15NO2 | 101692-94-8 | Details |
| 1-BCP | C13H15NO3 | 34023-62-6 | Details |
| Dehydroglyasperin D | C22H24O5 | 517885-72-2 | Details |
| 1,3-Dihydroxycyclobutane-1-carboxylic acid | C5H8O4 | 2227198-91-4 | Details |
| 4-Chlorophenylacetylene | C8H5Cl | 873-73-4 | Details |
| 4-Fluoro-2-methoxyaniline | C7H8FNO | 450-91-9 | Details |
| Methyl 2-O-(a-D-galactopyranosyl)-b-D-galactopyranoside | C13H24O11 | Details |
| Ethyl 5-amino-1-(1,1-dioxothiolan-3-yl)pyrazole-4-carboxylate | C10H15N3O4S | 1010863-54-3 | Details |
| PF-03549184 | C21H14Cl2N2O4S | 1221971-47-6 | Details |
| Alniditan | C17H26N4O | 152317-89-0 | Details |
| Sebuthylazine-2-hydroxy | C9H17N5O | 33124-61-7 | Details |
| GOT2 protein (His tag) | Details |
| N-(2-Aminoethyl)-1-methyl-1H-pyrazole-5-carboxamide | C7H12N4O | 442870-29-3 | Details |
| 5-Cyclopropyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-7-carboxylic acid | C11H8F3N3O2 | 1795475-02-3 | Details |
| OCT6 antibody | Details |
| Yixingensin | C23H24O12 | 158642-42-3 | Details |
| 4-Chloro-2,6-diiodophenol | C6H3ClI2O | 15459-50-4 | Details |
| (5-bromopyrimidin-2-yl)methanamine hcl | C5H7BrClN3 | 1240594-62-0 | Details |
| Desmethyl atomoxetine hydrochloride | C16H19NO.ClH | 881995-46-6 | Details |
| 4-O-(β-D-Mannopyranosyl)-D-glucose | C12H22O11 | 29276-55-9 | Details |
| 4-Chlorophenoxyacetyl Chloride | C8H6Cl2O2 | 4122-68-3 | Details |
| 2-Bromo-4-(difluoromethyl)pyridine | C6H4BrF2N | 1204295-87-3 | Details |
| 1-Methyl-3-[(4-methylphenyl)amino]pyrrolidine-2,5-dione | C12H14N2O2 | 41260-54-2 | Details |
| Methyl 2-(4,5-dimethoxy-2-(((4-methoxyphenyl)amino)sulfonyl)phenyl)acetate | C18H21NO7S | 1797917-60-2 | Details |
| tert-Butyl N-(1-cyanopiperidin-4-yl)carbamate | C11H19N3O2 | 721450-38-0 | Details |
| 2,3-Dihydrospiro[indene-1,3'-pyrrolidine] | C12H15N | 16976-98-0 | Details |
| Magnesium oxide | MgO | 1309-48-4 | Details |
| N-(4-Ethoxybenzyl)-n-methylamine | C10H15NO | 41690-86-2 | Details |
| Methyl 2-[4-(aminomethyl)cyclohexyl]acetate hydrochloride | C10H20ClNO2 | 2094938-79-9 | Details |
| FOXO3A Blocking Peptide | Details |
| ZNF284 Blocking Peptide | Details |
| H-QQQQQQQQQQQQQQQ-OH | Details |
| H-YDNSLK-OH | Details |
| 3-Methyl-1-oxa-3,7-diazaspiro[4.5]decan-2-one hydrochloride | C8H15ClN2O2 | 1390654-03-1 | Details |
| 2-[4-(Difluoromethoxy)-3-methoxyphenyl]ethan-1-amine hydrochloride | C10H14ClF2NO2 | 1311315-36-2 | Details |
| Phaseoloidin | C14H18O9 | 118555-82-1 | Details |
| [5-(Methoxymethyl)-1H-1,2,3-triazol-4-yl]methanamine | C5H10N4O | 120829-18-7 | Details |
| 2-Amino-1H-benzo[D]imidazole-5-carboxamide | C8H8N4O | 1207452-23-0 | Details |
| 3-(3-Fluorophenyl)piperidine | C11H14FN | 343856-71-3 | Details |
| HLA-A*02:01 Polymerase (400-408) | Details |
| 8-Hydroxy-4(Z),6(E),10(Z),13(Z),16(Z),19(Z)-docosahexaenoic acid | C22H32O3 | 90780-54-4 | Details |
| 1-Phenyl-1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine | C11H12N4 | 98175-84-9 | Details |
| Loxapine-d8 | C18H18ClN3O | 1189455-63-7 | Details |
| N-(3-Nitrophenyl)ethanediamide | C8H7N3O4 | 861332-65-2 | Details |
| Thymidine-3',5'-diphosphate disodium salt | C10H14N2Na2O11P2 | 386229-77-2 | Details |
| 4-(Pyridin-4-yloxy)benzoic acid hydrochloride | C12H10ClNO3 | 1306606-31-4 | Details |
| 3-Amino-1-(difluoromethyl)-1,2-dihydropyridin-2-one | C6H6F2N2O | 1263181-53-8 | Details |
| 3-Chloro-4-(chloromethyl)pyridine hydrochloride | C6H6Cl3N | 132685-21-3 | Details |
| Cycloheterophyllin | C30H30O7 | 36545-53-6 | Details |
| Thrombin Receptor Antagonist | C58H91N17O20S2 | 207553-92-2 | Details |
| KIF22 Blocking Peptide | Details |
| Recombinant Human FGF-8f | Details |
| 4-tert-Butyl-1,3-oxazole | C7H11NO | 52713-54-9 | Details |
| 1H,4H,5H,7H-Pyrano[3,4-b]pyrrol-7-one | C7H7NO2 | 1123725-74-5 | Details |
| KCNG4 Blocking Peptide | Details |
| Man-3-Xyl-Fuc N-Glycan | Details |
| Aniline-N,N-d2 | C6H5D2N | 1122-59-4 | Details |
| 7-Chloro-[1,2,3,4]tetrazolo[1,5-c]pyrimidin-8-amine | C4H3ClN6 | 3210-38-6 | Details |
| [3-(Methylamino)phenyl](phenyl)methanol | C14H15NO | 86997-98-0 | Details |
| rac-(1R,4R)-4-(1,3-Benzoxazol-2-yl)cyclohexan-1-amine | C13H16N2O | 412356-27-5 | Details |
| IL 4 Rhesus Macaque | Details |
| C1ORF110 antibody | Details |
| 2-Methyl-2-{[2-(trifluoromethyl)phenyl]methyl}pyrrolidine hydrochloride | C13H17ClF3N | 1989672-72-1 | Details |
| Methyl 2-(1,3-thiazol-5-yl)acetate | C6H7NO2S | 16565-78-9 | Details |
| 2-(4-Methoxyphenyl)propan-1-ol | C10H14O2 | 27877-68-5 | Details |
| 2-Chloro-N-{2-[4-(difluoromethoxy)phenyl]ethyl}acetamide | C11H12ClF2NO2 | 929973-52-4 | Details |
| Recoflavone | C20H18O8 | 203191-10-0 | Details |
| 4-(Pyridin-2-yl)butan-2-one | C9H11NO | 79476-33-8 | Details |
| (1S)-2-Amino-1-(3-fluorophenyl)ethan-1-ol hydrochloride | C8H11ClFNO | 2219353-93-0 | Details |
| 1-(4-Bromo-3-methylphenyl)pyrrolidin-2-one | C11H12BrNO | 197450-39-8 | Details |
| 5-(Pyrazin-2-yl)-1,3-thiazol-2-amine | C7H6N4S | 1339559-47-5 | Details |
| (5-Methyl-1,2-oxazol-3-yl)methanesulfonamide | C5H8N2O3S | 1042780-11-9 | Details |
| 3-Hydroxy-2-(4-methoxybenzenesulfonamido)butanoic acid | C11H15NO6S | 113793-31-0 | Details |
| UPRT protein (His tag) | Details |
| N-(1-Methylpiperidin-4-yl)-1H-indazol-6-amine | C13H18N4 | 416880-15-4 | Details |
| N-{[4-(Methylsulfanyl)phenyl]methyl}pyridin-2-amine | C13H14N2S | 91807-93-1 | Details |
| Mouse IL3 ELISA Kit | Details |
| N5-(5-Hydroxy-4,6-dimethyl-2-pyrimidinyl)-L-ornithine hydrochloride hydrate | C11H18N4O3 | 195143-52-3 | Details |
| rac-tert-Butyl (2R,6R)-4-benzyl-8-oxa-4-azatricyclo[7.4.0.0,2,6]trideca-1(13),9,11-triene-6-carboxylate | 2230799-06-9 | Details |
| GCN5L2 antibody | Details |
| 1-(1,4-Oxazepan-4-yl)ethan-1-one | C7H13NO2 | 1343066-95-4 | Details |
| 1-[(Cyclopropylcarbamoyl)methyl]cyclohexane-1-carboxylic acid | C12H19NO3 | 848316-26-7 | Details |
| Product Total： Product Page： | ||||
| 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 | ||||